Search Result "irreversible inhibitors"


Irreversible Protein Kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 2981-2994
Author(s): L. Garuti, M. Roberti, G. Bottegoni

Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3894-3900
Author(s): Paolo Maione,Antonio Rossi,Marianna Bareschino,Paola Claudia Sacco,Clorinda Schettino,Francesca Casaluce,Assunta Sgambato,Cesare Gridelli

Review Article

Cysteine-targeted Irreversible Inhibitors of Tyrosine Kinases and Key Interactions

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 31 Year: 2019 Page: 5811-5824
Author(s): Chunqi Hu,Xiaowu Dong

Review Article

Irreversible Kinase Inhibitors Targeting Cysteine Residues and their Applications in Cancer Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 20 Issue: 17 Year: 2020 Page: 1732-1753
Author(s): Debasis Das,Jian Hong

Epidermal Growth Factor Receptor Irreversible Inhibitors: Chemical Exploration of the Cysteine-Trap Portion

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1019-1030
Author(s): C. Carmi, A. Lodola, S. Rivara, F. Vacondio, A. Cavazzoni, R. R. Alfieri, A. Ardizzoni, P. G. Petronini, M. Mor

Cis-enone Resorcylic Acid Lactones (RALs) as Irreversible Protein Kinase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 9 Year: 2012 Page: 1186-1198
Author(s): Linyi Wei, Jiuhong Wu, Guanqun Li, Ning Shi

Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment

Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 19 Year: 2016 Page: 2179-2188
Author(s): Yi C. Zheng,Bin Yu,Guo Z. Jiang,Xue J. Feng,Peng X. He,Xiao Y. Chu,Wen Zhao,Hong M. Liu

Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 9 Year: 2014 Page: 775-793
Author(s): Deepa Subramaniam,Aiwu R. He,Jimmy Hwang,John Deeken,Michael Pishvaian,Marion L. Hartley,John L. Marshall

Perspective

Futibatinib: A Potent and Irreversible Inhibitor of Fibroblast GrowthFactor Receptors for Treatment of the Bile Duct Cancer

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 6 Year: 2024 Page: 666-670
Author(s): Surya K. De

Multi-Kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 22 Issue: 6 Year: 2015 Page: 695-712
Author(s): Laura Garuti,Marinella Roberti,Giovanni Bottegoni

Previous   Next

Go to   Results 1 - 1 of 5458

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads